Home | Publications | Healthcare place holder
place holder place holder

Healthcare

Allergan, Inc. Healthcare - Medical Equipment SWOT Report


Publication Date   May 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   35
ISBN Number   not applicable
Product Code   GMD514
Ask a question about this product?

Price £63.00

approximately: $109 | €80

Summary


Allergan, Inc. Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company's business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company's performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Report Coverage

  • Critical appraisal of the company's positioning using SWOT analysis.
  • Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.

Reasons to buy

  • Support business/sales activities by understanding customers' businesses better.
  • Identify prospective partners and suppliers.
  • Capitalize on your competitors weaknesses and target the market opportunities available to them.

Content


  • 1 Table of Contents
  • 1 Table of Contents
    • 1.1 List of Tables
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 SWOT Analysis
    • 5.1 Overview
    • 5.2 Allergan, Inc. Strengths
      • 5.2.1 Constant Growth of Revenues
      • 5.2.2 Leader in the New Medical Aesthetics Market
      • 5.2.3 Extensive Research and Development (R&D) Activities
      • 5.2.4 Fastest-Growing Global Eye Care Company
    • 5.3 Allergan, Inc. Weaknesses
      • 5.3.1 Lack of Global Diversity
      • 5.3.2 Patent Infringement Lawsuit
    • 5.4 Allergan, Inc. Opportunities
      • 5.4.1 Acquisitions
      • 5.4.2 Aging U.S population
      • 5.4.3 FDA Approvals
    • 5.5 Allergan, Inc. Threats
      • 5.5.1 Intense Competition
      • 5.5.2 Dependence on Collaborative Agreements
      • 5.5.3 Cost-Containment Pressures
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
    • 10.2 Other Locations & Subsidiaries
  • 11 Recent Developments
    • 11.1 Financial Announcements
      • 11.1.1 May 07, 2008: Allergan Declares Quarterly Dividend
      • 11.1.2 May 07, 2008: Allergan Declares Q1 2008 Results
      • 11.1.3 Jan 30, 2008: Allergan Declares Quarterly Dividend
      • 11.1.4 Jan 30, 2008: Allergan Declares Q4 2007 Results
      • 11.1.5 Nov 06, 2007: Allergan Declares Quarterly Dividend
      • 11.1.6 Nov 06, 2007: Allergan Declares Q3 2007 Results
      • 11.1.7 Aug 01, 2007: Allergan Reports Q2 2007 Results
      • 11.1.8 Aug 01, 2007: Allergan Declares Quarterly Dividend
      • 11.1.9 May 02, 2007: Allergan Reports Q1 2007 Results
      • 11.1.10 May 02, 2007: Allergan Declares Quarterly Dividend
      • 11.1.11 Jan 31, 2007: Allergan Reports Q4 2006 Results
      • 11.1.12 Jan 31, 2007: Allergan Declares Quarterly Dividend
    • 11.2 Other Significant Developments
      • 11.2.1 Dec 06, 2007: Allergan Appoints Board Member
  • 12 Appendix
    • 12.1 Methodology
    • 12.2 About Global Markets Direct
    • 12.3 Contact Us
    • 12.4 Disclaimer
  • List of Tables
    • Table 1: Allergan, Inc.,Key Facts
    • Table 2: Allergan, Inc., SWOT Analysis
    • Table 3: Allergan, Inc., Key Employees,
    • Table 4: Allergan, Inc., Subsidiaries
    • Table 5: Allergan, Inc., Subsidiaries,(Cont..)